16:8 Intermittent Fasting: What to Know
16:8 intermittent fasting means eating within an 8-hour window and fasting for the remaining 16 hours each day; research on this specific schedule shows modest weight and fat-mass reductions in some trials, no clear advantage over calorie restriction or alternate-day fasting in others, and a recurring, population-dependent signal of lean-mass loss.
Medical caution
This is general information about fasting, not medical advice. Fasting can affect blood sugar, blood pressure, medication timing, and nutritional status. Talk to a clinician before starting or changing a fasting practice if you are pregnant, under 18, living with diabetes or another chronic condition, taking prescription medication, or have a history of an eating disorder.
What the 16:8 Schedule Means
16:8 means eating all of a day's food within an 8-hour window and fasting for the remaining 16 hours, most commonly by skipping breakfast or dinner. It is one of several named intermittent-fasting schedules; see how to start intermittent fasting for how it compares to 5:2 and alternate-day fasting in the broader research.
Does It Matter When Your 8-Hour Window Is (Early vs. Late)
A 12-week trial in adults with overweight or obesity directly tested this question, comparing an early 8-hour window, a late 8-hour window, a self-selected 8-hour window, and usual-care education. Liver fat, measured by MRI, decreased within all three time-restricted-eating groups but not significantly more than usual care, and did not differ between early, late, or self-selected windows (Dote-Montero et al., 2026) [8]. In other words, in this trial, which 8 hours you choose does not appear to matter as much as whether you keep to a structured window at all; a significantly higher share of the time-restricted groups reached at least 5% weight loss than the usual-care group.
What the Research Shows
Weight and Fat Mass
A 3-month trial in people with obesity and type 2 diabetes found 16:8 fasting, done 3 days a week, produced a larger weight change than control, with improved fasting glucose, HbA1c, and lipids (Sukkriang and Buranapin, 2024) [3]; that protocol ran 3 days a week, not daily, which matters if this trial is cited as evidence for a daily 16:8 schedule. A meta-analysis of 15 trials combining exercise with 16:8 found the combination reduced body weight and fat mass versus exercise alone, with smaller improvements in triglycerides and LDL cholesterol, though the authors caution the evidence base is limited by study number, sample size, and inconsistent participant characteristics (Liu et al., 2026) [7]. Set against that, the largest pooled dataset available, a 2025 network meta-analysis of 99 randomized trials, did not find time-restricted eating beating ordinary calorie restriction; only alternate-day fasting showed that advantage (Semnani-Azad et al., 2025) [1]. Two trials have tested an 8-hour window directly against a calorie-matched comparison, with different results: the longest and largest, 12 months in 139 people with obesity, found no significant weight-loss advantage over calorie restriction alone (net difference -1.8 kg, 95% CI -4.0 to 0.4, p=0.11) (Liu et al., 2022) [11]; a shorter, 14-week trial in 90 adults with obesity found an earlier 8-hour window (7am to 3pm) more effective for weight loss than a wider eating window at the same weight-loss counseling (-2.3 kg, 95% CI -3.7 to -0.9, p=0.002) and improved diastolic blood pressure, though it did not significantly affect fat loss (Jamshed et al., 2022) [12].
Lean Mass: The Recurring Caveat
A dedicated, purpose-built 12-week trial testing daily 16:8 against three structured meals a day found no significant weight-loss advantage and a significant reduction in lean mass in the 16:8 group (appendicular lean mass index -0.16 kg per square meter, p=0.005) (Lowe et al., 2020) [2]. This is one of several directly relevant trials for a daily 8-hour-window schedule, not a pooled estimate, and it is the only one of them to report a significant lean-mass reduction; the lean-mass signal is worth taking seriously rather than treating 16:8 as cost-free for muscle, but it was not seen in the other direct trials on this page that reported lean mass.
Resistance Training and Muscle Gain
That caveat is not universal. A 12-week trial in 23 resistance-trained adults deliberately eating a calorie surplus to gain muscle found the 16:8 group had less fat gain and less body-weight gain than an unrestricted control group, while fat-free mass gains and strength gains were similar between groups (Gavanda et al., 2026) [5]. The 16:8 group ate less than its prescribed surplus, which the authors say explains the smaller fat gain, and body composition was measured by single-frequency bioimpedance, so this is not a clean test of the window alone. In this population, actively training and eating a surplus, an 8-hour window did not cost muscle or strength; the lean-mass caveat from the TREAT trial is population- and goal-dependent, not a universal finding.
Liver Fat and Gut Microbiota
See "Does It Matter When Your 8-Hour Window Is" above for the liver-fat trial's findings (Dote-Montero et al., 2026) [8]: time-restricted eating did not reduce liver fat more than usual-care education; the authors link the liver-fat reductions seen in the trial to weight loss and baseline fatty liver rather than to window timing, and note the trial was not powered for secondary outcomes. A structured 8-hour window still helped more participants reach a meaningful weight-loss threshold than usual care.
Cognitive Performance
A small 4-week pilot in 43 healthy women (23 fasting, 20 control) found 16:8 produced a significant BMI reduction versus control, with no significant difference in working memory or attentional-control test performance, and no difference in reported adverse events (McLeod et al., 2026) [6]. This is a small, short pilot; it supports "no evidence of cognitive harm" in this trial, not proof of cognitive benefit or impairment either way.
How 16:8 Compares to Other Schedules
Where 16:8 is compared directly against alternate-day fasting, in a 3-week trial in adults with prediabetes, alternate-day fasting outperformed 16:8 on weight and BMI reduction, though both beat control (Chair et al., 2022) [4]. For the broader comparison across intermittent fasting schedules generally, see how to start intermittent fasting. For the more extreme end of the daily-fasting spectrum, a single daily meal rather than an 8-hour window, see OMAD.
Getting Started
Pay attention to hydration and electrolytes during the fasting window; see electrolytes during a fast for the mechanism and warning signs, without a home dosing recommendation. For what counts as breaking the 16-hour window, see what breaks a fast.
Who Should Talk to a Clinician First
People on insulin, a sulfonylurea, or blood-pressure medication should only start 16:8 under clinician supervision; no 16:8-specific trial in this set tested that population directly, and this is the same standing caution carried from the general intermittent-fasting guide. Pregnancy, a history of an eating disorder, being under 18, and any chronic condition requiring consistent food or medication timing are reasons to get clinician guidance before starting, as a matter of general clinical caution rather than a specific finding from these trials.
Common Questions
Does 16:8 beat other schedules? Not clearly: the largest pooled estimate available does not show it beating calorie restriction, and a direct comparison found alternate-day fasting ahead of it on weight and BMI (Semnani-Azad et al., 2025 [1]; Chair et al., 2022 [4]). Does it cost muscle? That depends on the population and goal: it did in a weight-focused trial and did not in a muscle-gain-focused trial (Lowe et al., 2020 [2]; Gavanda et al., 2026 [5]). Does the time of day matter? Not for liver fat in the one trial that tested it directly (Dote-Montero et al., 2026) [8].
Safety and Cautions
This is general information, not medical advice. Lean or fat-free mass loss is a recurring but population-dependent signal, not a universal one: it showed up in a weight-focused trial and did not in a muscle-gain-focused trial, so state both rather than only one (Lowe et al., 2020 [2]; Gavanda et al., 2026 [5]). Most of this specific-schedule literature is short, three to twelve weeks in most of the trials reviewed here, though one trial followed participants for 12 months (Liu et al., 2022) [11]; shorter-trial results should not be read as durable or universal. Talk to a clinician before starting if pregnant, under 18, managing diabetes or blood pressure with medication, or with a history of an eating disorder.
What the evidence actually supports
16:8 has some dedicated supporting evidence for modest weight and fat-mass reduction: a 3-month trial in people with obesity and type 2 diabetes found 16:8 fasting, done 3 days a week, produced a larger weight change than control, with improved fasting glucose, HbA1c, and lipids (Sukkriang and Buranapin, 2024) [3]; and a meta-analysis of 15 trials combining exercise with 16:8 found the combination reduced body weight (mean difference -1.44 kg) and fat mass (-1.04 kg) versus exercise alone, with the authors cautioning that "the evidence base is limited by the small number of studies, modest sample sizes, and imbalance in participant characteristics" (Liu et al., 2026) [7]. But the largest pooled estimate available, a 2025 network meta-analysis of 99 trials, did not find time-restricted eating (the 16:8-type schedule) beating ordinary calorie restriction, where only alternate-day fasting showed that benefit (Semnani-Azad et al., 2025) [1]. The longest and largest trial testing an 8-hour window directly, 12 months, 139 people with obesity, found no significant difference in weight loss between 8-hour time-restricted eating plus calorie restriction and calorie restriction alone (net difference -1.8 kg, 95% CI -4.0 to 0.4, p=0.11) (Liu et al., 2022) [11]. A shorter, 14-week trial in 90 adults with obesity (59 completers in a secondary analysis) testing an early 8-hour window (7am to 3pm) against a wider eating window, both with the same weight-loss counseling, found the early window more effective for weight loss (-2.3 kg, 95% CI -3.7 to -0.9, p=0.002) and improved diastolic blood pressure, but it did not significantly affect fat loss or the ratio of fat loss to weight loss (Jamshed et al., 2022) [12]. A dedicated, purpose-built 12-week trial testing daily 16:8 against three structured meals found no significant between-group weight-loss difference and a significant reduction in lean mass in the 16:8 group (Lowe et al., 2020) [2]. Window timing does not appear to matter: a 12-week trial comparing early, late, and self-selected 8-hour windows against usual-care education found liver fat decreased within all three time-restricted-eating groups but not significantly more than usual care, and did not differ by window timing; a significantly higher share of the time-restricted groups reached a 5% or greater weight-loss threshold than usual care (41-44% vs 16%, p=0.001) (Dote-Montero et al., 2026) [8].
Where the studies disagree
The lean-mass caveat from the TREAT trial (Lowe et al., 2020) [2] is population- and goal-dependent, not universal: a 12-week trial in resistance-trained adults deliberately eating a calorie surplus found a 16:8 window was associated with less fat gain (+2.00 vs +4.36 kg, p=0.009) and less body-weight gain (+2.19 vs +3.90 kg, p=0.018) than an unrestricted control group, while fat-free mass gains and strength gains (deadlift, bench press) were similar between groups; the 16:8 group ate less than its prescribed calorie surplus, which the authors say explains the smaller fat gain, and body composition was measured by single-frequency bioimpedance (Gavanda et al., 2026) [5]. Two directly comparable 8-hour-window trials point in different directions on weight loss: the longer, larger one found no significant advantage over calorie restriction alone (Liu et al., 2022) [11], while the shorter one found an early 8-hour window did outperform a wider window on weight loss, though not on fat loss specifically (Jamshed et al., 2022) [12]. Where 16:8 is compared directly against alternate-day fasting, alternate-day fasting wins on weight and BMI reduction (Chair et al., 2022) [4]. On window timing specifically, the liver-fat trial above found no significant difference between early, late, or self-selected 8-hour windows, and did not reduce liver fat more than usual-care education; the authors link the liver-fat reductions to weight loss and baseline fatty liver rather than to window timing, and note the trial was not powered for secondary outcomes, even though more time-restricted-eating participants reached a meaningful weight-loss threshold (Dote-Montero et al., 2026) [8]; these are two separate, non-contradictory findings that should not be collapsed into a single "TRE beats usual care on liver health" claim. A small 4-week pilot in 43 women found a significant BMI reduction with 16:8 versus control, with no significant difference in working memory or attentional-control performance and no difference in reported adverse events (McLeod et al., 2026) [6]; this is a small pilot, so it supports "no evidence of cognitive harm" rather than proof of cognitive benefit or impairment either way. The most rigorous evidence-quality reviews available rate nearly all of this literature low to very low certainty: a Cochrane review found no study reporting on mortality, stroke, or heart attack at any follow-up (Allaf et al., 2021) [9], and an umbrella review of 130 trials found only 1% of 104 pooled findings were backed by high-quality evidence, with reduced fat-free mass a recurring pattern (Patikorn et al., 2021) [10].
References
- Semnani-Azad Z, Khan TA, Chiavaroli L, Chen V, Bhatt HA, Chen A, Chiang N, Oguntala J, Kabisch S, Lau DC, Wharton S, Sharma AM, Harris L, Leiter LA, Hill JO, Hu FB, Lean ME, Kahleová H, Rahelic D, Salas-Salvadó J, Kendall CW, Sievenpiper JL (2025). Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors, systematic review and network meta-analysis of randomised clinical trials. BMJ. PMID 40533200 doi:10.1136/bmj-2024-082007 Finding: limited evidence
- Lowe DA, Wu N, Rohdin-Bibby L, Moore AH, Kelly N, Liu YE, Philip E, Vittinghoff E, Heymsfield SB, Olgin JE, Shepherd JA, Weiss EJ (2020). Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity, the TREAT Randomized Clinical Trial. JAMA Internal Medicine. PMID 32986097 doi:10.1001/jamainternmed.2020.4153 Finding: contradicts
- Sukkriang N, Buranapin S (2024). Effect of intermittent fasting 16:8 and 14:10 compared with control group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients, a randomized controlled trial. Journal of Diabetes Investigation. PMID 38932663 doi:10.1111/jdi.14186 Finding: supports
- Chair SY, Cai H, Cao X, Qin Y, Cheng HY, Ng MT (2022). Intermittent Fasting in Weight Loss and Cardiometabolic Risk Reduction, a Randomized Controlled Trial. Journal of Nursing Research. PMID 35050952 doi:10.1097/jnr.0000000000000469 Finding: limited evidence
- Gavanda S, Arnet L, Löffler D, Dissemond J, Havers T, Wiewelhove T, Geisler S, Held S, Brinkmann C, Isenmann E (2026). Time-Restricted Eating during a Bulking Phase Is Associated with Reduced Fat Accumulation, while Muscle and Strength Gains Are Maintained: A 12-Wk Randomized Controlled Trial. The Journal of Nutrition. PMID 42442697 doi:10.1016/j.tjnut.2026.101722 Finding: limited evidence
- McLeod SC, Surrey T, McCormack JC, Conner TS, Peng M (2026). Impact of a 4-week time-restricted eating (16:8) intervention on working memory and attentional control in adult women: A randomized controlled pilot. Acta Psychologica. PMID 42520714 doi:10.1016/j.actpsy.2026.107510 Finding: limited evidence
- Liu H, Hu G, Ma X (2026). Effects of combining exercise with a 16:8 time-restricted eating protocol on body composition and glucose-lipid metabolism in adults, a systematic review and meta-analysis. Frontiers in Nutrition. PMID 42221753 doi:10.3389/fnut.2026.1816555 Finding: supports
- Dote-Montero M, Clavero-Jimeno A, Cortés-Martín A, Lopez-Pascual A, Merchán-Ramírez E, Camacho-Cardenosa A, Concepción M, Osés M, López-Vázquez A, Amaro-Gahete FJ, Martin-Olmedo JJ, Jurado-Fasoli L, De-la-O A, García Pérez PV, Gálvez J, Rodriguez-Nogales A, Garcia F, Habimana CM, Vázquez MJ, Alfaro-Magallanes VM, Avila MA, Martín-Rodríguez JL, Cabeza R, Muñoz-Torres M, Labayen I, Ruiz JR (2026). Time-restricted eating, liver health, and fecal microbiota in adults with overweight or obesity: A randomized controlled trial. JHEP Reports. PMID 42413768 doi:10.1016/j.jhepr.2026.101956 Finding: limited evidence
- Allaf M, Elghazaly H, Mohamed OG, Fareen MFK, Zaman S, Salmasi AM, Tsilidis K, Dehghan A (2021). Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database of Systematic Reviews. PMID 33512717 doi:10.1002/14651858.CD013496.pub2 Finding: limited evidence
- Patikorn C, Roubal K, Veettil SK, Chandran V, Pham T, Lee YY, Giovannucci EL, Varady KA, Chaiyakunapruk N (2021). Intermittent Fasting and Obesity-Related Health Outcomes, an Umbrella Review of Meta-analyses of Randomized Clinical Trials. JAMA Network Open. PMID 34919135 doi:10.1001/jamanetworkopen.2021.39558 Finding: limited evidence
- Liu D, Huang Y, Huang C, Yang S, Wei X, Zhang P, Guo D, Lin J, Xu B, Li C, He H, He J, Liu S, Shi L, Xue Y, Zhang H (2022). Calorie Restriction with or without Time-Restricted Eating in Weight Loss. New England Journal of Medicine. PMID 35443107 doi:10.1056/NEJMoa2114833 Finding: no effect found
- Jamshed H, Steger FL, Bryan DR, Richman JS, Warriner AH, Hanick CJ, Martin CK, Salvy SJ, Peterson CM (2022). Effectiveness of Early Time-Restricted Eating for Weight Loss, Fat Loss, and Cardiometabolic Health in Adults With Obesity: A Randomized Clinical Trial. JAMA Internal Medicine. PMID 35939311 doi:10.1001/jamainternmed.2022.3050 Finding: limited evidence